M ETHODS IN MOLECULAR BIOLOGY Series Editor John M. Walker School of Life Sciences University of Hertfordshire Hatfield, Hertfordshire, AL10 9AB, UK For other titles published in this series, go to www.springer.com/series/7651
iii Type 2 Diabetes Methods and Protocols Edited by Claire Stocker Clore Laboratory, University of Buckingham, Hunter Street, Buckingham, UK
iv Editor Claire Stocker, Ph.D. Clore Laboratory University of Buckingham Hunter Street Buckingham United Kingdom MK18 1EG claire.stocker@buckingham.ac.uk ISSN: 1064-3745 e-issn: 1940-6029 ISBN: 978-1-934115-15-2 e-isbn: 978-1-59745-448-3 DOI: 10.1007/978-1-59745-448-3 Springer Dordrecht Heidelberg London New York Library of Congress Control Number: 2009922609 Humana Press, a part of Springer Science+Business Media, LLC 2009 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Humana Press, c/o Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is for-bidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com)
Preface Diabetes is now reaching epidemic proportions, and the associated complications of this disease can be life threatening and disabling. Over recent years, both clinical and basic researchers have increased our understanding of the mechanisms involved in the progression of diabetes and the relative roles played by both environmental and genetic factors. For example, it is well known that a lifestyle of inactivity and excessive food intake plays an important part in diabetes risk. The purpose of this volume is to provide up-to-date explanations of commonly used laboratory protocols used in diabetes research. Specifically, the chapters will cover the commonly described in vivo and in vitro model systems, ultimately leading to an overall view of how cellular dysfunction and degeneration lead to susceptibility and diabetes disease progression. This book is unique in providing a simple explanation of a particular practical technique or model in a short succinct format, thus allowing research scientists and clinicians quick and easy practical information to address a particular question. There are key practical notes at the end of each chapter, as well as numerous helpful tables and figures. Claire Stocker Buckingham, UK v
Contents Preface... Contributors... v ix 1. Selecting the Right Mouse Model for Metabolic Syndrome and Type 2 Diabetes Research... 1 Edward H. Leiter 2. Nutritional Models of Type 2 Diabetes Mellitus... 19 Beverly Sara Mühlhausler 3. The Isolation and Purification of Rodent Pancreatic Islets of Langerhans... 37 Jacqueline F. O Dowd 4. The Measurement of Insulin Secretion from Isolated Rodent Islets of Langerhans... 43 Anna L. Nolan and Jacqueline F. O Dowd 5. The Incubation and Monitoring of Cell Viability in Primary Rat Islets of Langerhans and Pancreatic β-cell Lines... 53 Noel G. Morgan, Eleftheria Diakogiannaki, and Mark A. Russell 6. In Vitro Culture of Isolated Islets of Langerhans: Analysis of Function... 65 Anna L. Nolan 7. Single-Cell RT-PCR Identification of Genes Expressed by Human Islet Endocrine Cells... 73 Dany Muller, Peter M. Jones, and Shanta J. Persaud 8. Laser Capture Microdissection of Human Pancreatic β-cells and RNA Preparation for Gene Expression Profiling... 87 Lorella Marselli, Dennis C. Sgroi, Susan Bonner-Weir, and Gordon C. Weir 9. In Vitro Transdifferentiation of Human Hepatoma Cells into Pancreatic-Like Cells... 99 Wan-Chun Li 10. The Measurement of GLUT4 Translocation in 3T3-L1 Adipocytes... 111 Nicky Konstantopoulos and Juan Carlos Molero-Navajas 11. Pancreatic Remodeling: Beta-Cell Apoptosis, Proliferation and Neogenesis, and the Measurement of Beta-Cell Mass and of Individual Beta-Cell Size... 137 Eduard Montanya and Noèlia Téllez 12. Morphology of Pancreatic Islets: A Time Course of Pre-diabetes in Zucker Fatty Rats... 159 Petra Augstein and Eckhard Salzsieder 13. Fluorescent Immunohistochemistry and In Situ Hybridization Analysis of Pancreas... 191 Xiuli Wang, Shundi Ge, and Gay M. Crooks vii
viii Contents 14. The Measurement of Insulin Secretion Using Pancreas Perfusion in the Rodent... 203 Edward T. Wargent 15. Hyperinsulinemic Euglycemic Clamp to Assess Insulin Sensitivity In Vivo... 221 Jason K. Kim 16. Gene Expression Analysis in Diabetes Research... 239 Peter White and Klaus H. Kaestner 17. Gene Expression Mining in Type 2 Diabetes Research... 263 Donald R. Dunbar Index... 273
Contributors PETRA AUGSTEIN Institute of Diabetes Gerhardt Katsch Karlsburg e.v., Karlsburg, Germany SUSAN BONNER-WEIR Section on Islet Transplantation and Cell Biology, Research Division, Joslin Diabetes Center and the Department of Medicine, Harvard Medical School, Boston, MA, USA GAY M. CROOKS Division of Research Immunology/BMT, Childrens Hospital Los Angeles, Los Angeles, CA, USA ELEFTHERIA DIAKOGIANNAKI Institute of Biomedical and Clinical Science, Peninsula Medical School, Plymouth, Devon, UK DONALD R. DUNBAR Centres for Cardiovascular Science and Inflammation Research, Queen s Medical Research Institute, University of Edinburgh, Edinburgh, UK SHUNDI GE Division of Research Immunology/BMT, Childrens Hospital Los Angeles, Los Angeles, CA, USA PETER M. JONES Beta Cell Development & Function Group, King s College London, London, UK KLAUS H. KAESTNER Department of Genetics and Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, PA, USA JASON K. KIM Division of Endocrinology, Metabolism and Diabetes Director, UMass Mouse Phenotyping Center University of Massachusetts Medical School, 381 Plantation Street, Suite 200 Worcester, MA, USA NICKY KONSTANTOPOULOS Metabolic Research Unit, Deakin University, Geelong, VIC, Australia EDWARD H. LEITER The Jackson Laboratory, Bar Harbor, ME, USA WAN-CHUN LI Section of Islet Transplantation and Cell Biology, Joslin Diabetes Center, Boston, MA, USA LORELLA MARSELLI Section on Islet Transplantation and Cell Biology, Research Division, Joslin Diabetes Center and the Department of Medicine, Harvard Medical School, Boston, MA, USA JUAN CARLOS MOLERO-NAVAJAS Metabolic Research Unit, Deakin University, Geelong, VIC, Australia EDUARD MONTANYA Endocrine Unit, University Hospital of Bellvitge, Barcelona, Spain Department of Clinical Sciences, University of Barcelona, Barcelona, Spain Biomedical Research Institute of Bellvitge (IDIBELL), L Hospitalet de Llobregat, Barcelona, Spain NOEL G. MORGAN Institute of Biomedical and Clinical Science, Peninsula Medical School, Plymouth, Devon, UK ix
x Contributors BEVERLY SARA MŰHLHAUSLER Early Origins of Adult Health Research Group, Sansom Research Institute, University of South Australia, Adelaide, SA, Australia DANY MULLER Beta Cell Development & Function Group, King s College London, London, UK ANNA L. NOLAN Elixir Pharmaceuticals, Cambridge, MA, USA JACQUELINE F. O DOWD Clore Laboratory, University of Buckingham, Buckingham, Buckinghamshire, UK SHANTA J. PERSAUD Beta Cell Development & Function Group, King s College London, London, UK MARK A. RUSSELL Institute of Biomedical and Clinical Science, Peninsula Medical School, Plymouth, Devon, UK ECKHARD SALZSIEDER Institute of Diabetes Gerhardt Katsch Karlsburg e.v., Karlsburg, Germany DENNIS C. SGROI Molecular Pathology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA NOÈLIA TÉLLEZ Biomedical Research Institute of Bellvitge (IDIBELL), L Hospitalet de Llobregat, Barcelona, Spain XIULI WANG Division of Research Immunology/BMT, Childrens Hospital Los Angeles, Los Angeles, CA, USA, Division of Cancer Immunotherapeutics and Tumor Immunology, City of Hope National Medical Center, Duarte, CA, USA EDWARD T. WARGENT Clore Laboratory, University of Buckingham, Buckingham, Buckinghamshire, UK GORDON C. WEIR Section on Islet Transplantation and Cell Biology, Research Division, Joslin Diabetes Center and the Department of Medicine, Harvard Medical School, Boston, MA, USA PETER WHITE Director, Biomedical Genomics Core, Research Assistant Professor of Pediatrics, The Research Institute at Nationwide Children s Hospital and The Ohio State University